A carregar...

Pharmacological properties of faster‐acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double‐blind, crossover trial

AIM: To evaluate the pharmacological characteristics of faster‐acting insulin aspart (faster aspart) compared with insulin aspart (IAsp) during continuous subcutaneous insulin infusion (CSII). METHODS: In this randomized, double‐blind, crossover trial, 48 men and women aged 18 to 64 years with type...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Heise, Tim, Zijlstra, Eric, Nosek, Leszek, Rikte, Tord, Haahr, Hanne
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5299522/
https://ncbi.nlm.nih.gov/pubmed/27709762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12803
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!